Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
no down pressure...only one way to go :)
[Suppressed Sound Link]
somebody dropped some coin in here for a reason...
we shall see
it's always spottier before it's hottier
has the green light...matter of who recognizes it
[Suppressed Sound Link]
420 prints.. interesting
that woke up a few, lol
turning perfectly so far
[Suppressed Sound Link]
intra bottom area
guessing there's a big share "imbalance" here :)
yep.. not too thin.. just right
[Suppressed Sound Link]
pause, go, pause, go :)
[Suppressed Sound Link]
.0027 taps :)
[Suppressed Sound Link]
how bout 52high before we find out why
ONCI gap closed w/ nice bids
could be a shoulda woulda
[Suppressed Sound Link]
AXPW movin
.0026 seems like next spot
with gusto
bar set @.007 for now...then bets off :)
[Suppressed Sound Link]
looks like 13 is key so.. nice hit
[Suppressed Sound Link]
lmao.. puking chasers
yes.. good morning lol
or time to get rollin lol
420 hits @ .001 hmmm
[Suppressed Sound Link]
yep...get 1 on bid, bets are off imo
startin to get around
science and progress
.018 movin right along
SCIE .0036 news...
SpectraScience Announces Licensing of Key Technology From Duke University
SAN DIEGO, CA -- (Marketwired) -- 05/03/16 -- SpectraScience, Inc. (OTCQB: SCIE), a medical device company utilizing light technologies to detect and diagnose cancers, announced today that they have concluded a licensing agreement with Duke University. The technology covered is around systems and methods for the use of Angle-Resolved Low Coherence Interferometry in the diagnosis of certain cancers.
"We are excited to be working with an institution as prestigious as Duke University to advance medical diagnostics," said Michael Oliver, President and Chief Executive Officer of SpectraScience, Inc. "The intellectual property we have licensed from Duke is the underlying technology for the Oncoscope products we acquired earlier this year. With the potential to develop a product for light-based diagnosis of Barrett's Esophagus, a precursor to esophageal cancer, we are continuing to broaden our product offerings. Our goal is to be the premier company using light to provide invivo diagnosis of cancer."
About SpectraScience, Inc.:
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. Protected by more than 30 patents in 28 countries, covering fundamental elements of the technology, the WavSTAT Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative patent protected technology for clinical use.
For more information:
Visit our web site www.spectrascience.com
Forward-Looking Statement for SpectraScience, Inc.
This news release contains forward-looking statements that involve risks and uncertainties that may cause SpectraScience's actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, its most recent Form 10-K and in SpectraScience's other reports filed with the Securities and Exchange Commission ("SEC") that attempt to advise interested parties of the risks and factors that may affect SpectraScience's business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-K and other documents.
Contacts:
Media and Investors:
SpectraScience, Inc.
Lowell Giffhorn
CFO
Phone: (858) 847-0200 x2019
Email: lgiffhorn@spectrascience.com
Source: SpectraScience, Inc.
9 is the trigger
[Suppressed Sound Link]
here's .0009
[Suppressed Sound Link]
something going on f'sure...we shall see
[Suppressed Sound Link]